Equasens SA 2023 IR
The report highlights Equasens Group's financial and operational performance for the fiscal year 2023, emphasizing its transition toward a SaaS-based business model. The company expanded its European footprint, notably in Germany through the acquisition of ADV (now Pharmagest Germany), and integrated speech recognition and training capabilities. Equasens continued to advance its patient-centered healthcare technology strategy, promoting interoperability through its pandaLAB Pro platform. On the environmental front, the Group conducted its first comprehensive carbon footprint assessment and successfully recycled 9,344 IT machines through its circular economy initiatives.
Company: Equasens SA
Sector: Health Care
Country: France
Year: 2023
Type: IR
Pages: 228
Equasens SA
Universal Registration Document
The report highlights Equasens Group's financial and operational performance for the fiscal year 2023, emphasizing its transition toward a SaaS-based business model. The company expanded its European footprint, notably in Germany through the acquisition of ADV (now Pharmagest Germany), and integrated speech recognition and training capabilities. Equasens continued to advance its patient-centered healthcare technology strategy, promoting interoperability through its pandaLAB Pro platform. On the environmental front, the Group conducted its first comprehensive carbon footprint assessment and successfully recycled 9,344 IT machines through its circular economy initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women on Board
Women in Management
Employees